SFA
SGYP

Sequoia Financial Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Sequoia Financial Advisors’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-18,226
Closed -$85K – 304
2017
Q1 		$85K Hold
18,226
– – 0.01% 276
2016
Q4 		$111K Buy
18,226
+2,016
+12% +$10.5K 0.02% 264
2016
Q3 		$89K Hold
16,210
– – 0.02% 241
2016
Q2 		$62K Hold
16,210
– – 0.02% 246
2016
Q1 		$45K Buy
16,210
+6,000
+59% +$21.7K 0.01% 195
2015
Q4 		$58K Buy
+10,210
New +$62.2K 0.02% 172

Other funds holding SGYP

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Sequoia Financial Advisors's SGYP Position: Q2 2017 in Review

Sequoia Financial Advisors sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2017, closing a stake of 18,226 shares — an estimated $85K sold.

Sequoia Financial Advisors first reported a position in SGYP in Q4 2015 and held it in 6 quarters. The position peaked at $111K in Q4 2016. 146 funds tracked by Wall St. Rank hold SGYP as of Q2 2017.

  • Sequoia Financial Advisors reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2017 after selling out during the quarter.
  • Sequoia Financial Advisors sold 18,226 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2017, an estimated $85K.
  • Sequoia Financial Advisors first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2015 and held it in 6 quarters.
  • Sequoia Financial Advisors's Synergy Pharmaceuticals, Inc Common Stock position peaked at $111K in Q4 2016.
  • 146 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2017.

Based on Sequoia Financial Advisors's 13F filing for Q2 2017, filed 9 Aug 2017.